Fairmount Funds Management

Fairmount Funds Management as of Dec. 31, 2020

Portfolio Holdings for Fairmount Funds Management

Fairmount Funds Management holds 18 positions in its portfolio as reported in the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Insmed Com Par $.01 (INSM) 11.5 $32M 962k 33.29
Amicus Therapeutics (FOLD) 10.9 $30M 1.3M 23.09
Iovance Biotherapeutics (IOVA) 9.4 $26M 566k 46.40
ACADIA Pharmaceuticals (ACAD) 8.6 $24M 450k 53.46
Trillium Therapeutics Com New 7.8 $22M 1.5M 14.71
Allakos (ALLK) 7.4 $21M 148k 140.00
Zogenix Com New 7.0 $20M 981k 19.99
Axsome Therapeutics (AXSM) 6.4 $18M 220k 81.47
Cogent Biosciences (COGT) 6.3 $18M 1.6M 11.23
Argenx Se Sponsored Adr (ARGX) 5.3 $15M 50k 294.09
Mirati Therapeutics 4.8 $13M 61k 219.64
Karyopharm Therapeutics (KPTI) 3.9 $11M 702k 15.48
Global Blood Therapeutics In 3.3 $9.3M 215k 43.31
Amarin Corp Spons Adr New (AMRN) 2.6 $7.4M 1.5M 4.89
Enanta Pharmaceuticals (ENTA) 2.3 $6.3M 150k 42.10
Seres Therapeutics (MCRB) 2.3 $6.3M 257k 24.50
Verona Pharma Sponsored Ads (VRNA) 0.3 $700k 100k 7.00
Miragen Therapeutics Com New 0.2 $554k 35k 15.79